These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37083806)

  • 1. Anti-SOX1 antibodies-positive paraneoplastic neurological syndromes caused by thyroid carcinoma: A case report.
    Deng Y; Zhang X; Wang L; Lu X; Gao Y; Wu Z; Zhong Z
    Medicine (Baltimore); 2023 Apr; 102(16):e33499. PubMed ID: 37083806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies.
    Arnaldos-Pérez C; Vilaseca A; Naranjo L; Sabater L; Dalmau J; Ruiz-García R; Graus F
    Front Immunol; 2023; 14():1173484. PubMed ID: 37207233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert-Eaton myasthenic syndrome and small cell lung cancer: A case report.
    Li C; Wang X; Sun L; Deng H; Han Y; Zheng W
    Thorac Cancer; 2020 Feb; 11(2):465-469. PubMed ID: 31880403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
    Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
    Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of anti-SOX1 and anti-GABAB receptor antibodies with paraneoplastic limbic encephalitis presenting with seizures and memory impairment in small cell lung cancer: A case report.
    Gong S; Han Y; He E; Liu M; Fu X; Deng F
    Front Immunol; 2022; 13():955170. PubMed ID: 35967304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of anti-SOX1 reactivity in various neurological disorders.
    Berger B; Dersch R; Ruthardt E; Rasiah C; Rauer S; Stich O
    J Neurol Sci; 2016 Oct; 369():342-346. PubMed ID: 27653921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-SOX1 Antibodies in Paraneoplastic Neurological Syndrome.
    Sun X; Tan J; Sun H; Liu Y; Guan W; Jia J; Wang Z
    J Clin Neurol; 2020 Oct; 16(4):530-546. PubMed ID: 33029958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques.
    Vabanesi M; Pinto AL; Vogrig A; Goncalves D; Rogemond V; Joubert B; Fabien N; Honnorat J; Muñiz-Castrillo S
    J Neurol; 2023 Mar; 270(3):1691-1701. PubMed ID: 36512064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
    Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
    J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations.
    Ruiz-García R; Martínez-Hernández E; García-Ormaechea M; Español-Rego M; Sabater L; Querol L; Illa I; Dalmau J; Graus F
    Front Immunol; 2019; 10():769. PubMed ID: 31031763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the spectrum of SOX1-antibodies in neuropathy: the coexistence of anti-SOX1 and Guillain-Barré syndrome-a case report.
    Coniglio S; Turchi G; Giovannini G; Mazzoli M; Meletti S; Vaudano AE
    Neurol Sci; 2022 Jun; 43(6):3979-3982. PubMed ID: 35391602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated treatment for autonomic paraneoplastic syndrome improves performance status in a patient with small lung cell carcinoma: a case report.
    Ueno T; Hasegawa Y; Hagiwara R; Kon T; Nunomura JI; Tomiyama M
    BMC Neurol; 2018 Nov; 18(1):189. PubMed ID: 30414621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
    Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
    Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic neurological syndromes in patients affected by SCLC: a case series.
    Zanella C; Leone AG; Zambelli L; Bottiglieri A; Canziani L; Brambilla M; Lo Russo G; Platania M; De Braud F; Occhipinti M
    Tumori; 2022 Dec; 108(6):NP11-NP14. PubMed ID: 35260015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy.
    Tschernatsch M; Singh P; Gross O; Gerriets T; Kneifel N; Probst C; Malas S; Kaps M; Blaes F
    J Neuroimmunol; 2010 Sep; 226(1-2):177-80. PubMed ID: 20701982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
    Vural B; Chen LC; Saip P; Chen YT; Ustuner Z; Gonen M; Simpson AJ; Old LJ; Ozbek U; Gure AO
    Cancer; 2005 Jun; 103(12):2575-83. PubMed ID: 15880380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
    Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
    JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
    Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S
    Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer.
    Wang L; Lou H; Li B; Li J; Yang YM
    Invest New Drugs; 2022 Feb; 40(1):151-156. PubMed ID: 34287773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.